Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
p27Kip1 controls cytokinesis via the regulation of citron kinase activation
Murielle P. Serres, … , Nisar P. Malek, Arnaud Besson
Murielle P. Serres, … , Nisar P. Malek, Arnaud Besson
Published February 1, 2012
Citation Information: J Clin Invest. 2012;122(3):844-858. https://doi.org/10.1172/JCI60376.
View: Text | PDF
Research Article Oncology

p27Kip1 controls cytokinesis via the regulation of citron kinase activation

  • Text
  • PDF
Abstract

p27Kip1 (p27) acts as a tumor suppressor by inhibiting cyclin–cyclin-dependent kinase (cyclin-CDK) activity. However, mice expressing a form of p27 that is unable to bind or inhibit cyclin-CDK complexes (p27CK–) have increased incidence of tumor development as compared with wild-type and p27–/– mice, revealing an oncogenic role for p27. Here, we identified a phenotype of multinucleation and polyploidy in p27CK– mice not present in p27–/– animals, suggesting a role for p27 in G2/M that is independent of cyclin-CDK regulation. Further analysis revealed that p27CK– expression caused a cytokinesis and abscission defect in mouse embryonic fibroblasts. We identified the Rho effector citron kinase (citron-K) as a p27-interacting protein in vitro and in vivo and found that p27 and citron-K colocalized at the contractile ring and mid-body during telophase and cytokinesis. Moreover, overexpression of the minimal p27-binding domain of citron-K was sufficient to rescue the phenotype caused by p27CK–. Conversely, expression of a mutant p27CK– unable to bind citron-K did not induce multinucleation. Finally, by binding to citron-K, p27 prevented the interaction of citron-K with its activator RhoA. Taken together, these data suggest a role for p27 during cytokinesis via the regulation of citron-K activity.

Authors

Murielle P. Serres, Uta Kossatz, Yong Chi, James M. Roberts, Nisar P. Malek, Arnaud Besson

×

Figure 3

p27CK– causes a cytokinesis defect.

Options: View larger image (or click on image) Download as PowerPoint
p27CK– causes a cytokinesis defect.
   
(A) Multinucleation was quantifi...
(A) Multinucleation was quantified (500 cells counted/line, n = 3) in two lines of immortalized p27–/– MEFs infected or not with p27CK– and stained for β-catenin and lamin-A (original magnification, ×400). p27CK– levels following retroviral infection were measured by immunoblot for p27, and β-tubulin levels were used as loading control. Lower graph: For each cell line, the proportion of mitotic cells in telophase and cytokinesis was determined in 50–100 mitotic figures; results are mean of 5 independent experiments. (B) Overexpression of p27CK– in HeLa cells causes multinucleation. HeLa cells were transfected with either empty vector or a vector encoding p27CK–. Transfected cells were visualized by p27 staining and co-labeled for β-catenin, and 600 p27-positive cells were counted (original magnification, ×400). Graphs show the average number of multinucleated cells in 3 independent experiments. Right graph: number of mitotic cells in telophase and cytokinesis observed in 100 mitotic figures (n = 4). In A and B, *P < 0.05, **P < 0.01, Student’s t test. (C) Number of mitotic cells in cytokinesis in immortalized p27+/+, p27–/–, and p27CK– MEFs. One hundred mitotic figures were counted per genotype in 3 independent experiments. Results were analyzed by 1-way ANOVA with the Tukey-Kramer multiple comparison test; p27+/+ versus p27CK–, **P < 0.01. Error bars in A–C represent SEM. (D–H) Videomicroscopy of p27+/+, p27–/–, and p27CK– MEFs undergoing mitosis. (D) Incidence of multinucleation caused by cytokinetic regression relative to the total number of mitotic figures recorded (p27+/+: n = 181; p27–/–: n = 117; p27CK–: n = 243). (E) Nature of the defect causing multinucleation: multinucleation caused by reopening of the intercellular bridge as a percentage of the total number of multinucleation was determined for each genotype. (F–H) Examples of phase contrast videomicroscopy of mitotic p27+/+ (F) and p27CK– MEFs (G and H). Arrows indicate the intercellular bridge. In p27CK–, cells undergo mitosis normally until the formation of intercellular bridge, which regresses to form binucleated cells. Original magnification, ×200.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts